Original articleFibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden Monica study
References (31)
- et al.
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study
Lancet
(1986) - et al.
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
Atherosclerosis
(1991) - et al.
Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and rela tive body weight in normal and obese subjects
Metabolism
(1986) - et al.
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor1
Metabolism
(1990) - et al.
Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden
J Clin Epidemiol
(1989) - et al.
A functional photometric assay for plasma fibrinogen
Thromb Res
(1984) - et al.
Plasminogen activator release during venous stasis and exercise as demonstrated by a new specific assay
Clin Chim Acta
(1983) - et al.
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
Thromb Res
(1983) - et al.
Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen
Fibrinolysis
(1993) - et al.
Inequalities in death-specific explanations of a general pattern?
Lancet
(1984)
Fibrinogen and risk of cardiovascular disease
JAMA
(1987)
Fibrinogen as a risk factor for stroke and myocardial infarction
N Engl J Med
(1984)
Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
N Engl J Med
(1980)
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction
Lancet
(1987)
Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death
Br Heart J
(1991)
Cited by (0)
Copyright © 1994 Published by Elsevier Inc.